Skip to content

Sana Biotechnology SANA Book value per share

Book value per share at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$75.54+18.8%
Gilead Sciences logo
Gilead SciencesGILD
$18.75+23.2%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$18.89-11.2%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$1.16-35.1%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$9.17-33.5%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$1.52+372%

Other financials

Income statement

See full
Operating income-$48.6M+4.0%
Net income-$47.2M+4.4%
EPS (diluted)-$0.17+19.0%

Balance sheet

See full
Cash & equivalents$83.8M-12.8%
Total debt$75.3M-17.5%
Total equity$119.2M-43.0%
Total assets$373.6M-16.1%

Cash flow

See full
Operating cash flow-$37.4M+23.2%
CapEx$288.0K+112%
Free cash flow-$37.7M+22.8%

Valuation

See full
Market cap$907.23M+54.1%
Enterprise value$898.76M+53.9%

Returns & leverage

See full
Return on equity-147.4%-2,468pp
Debt / equity0.6×+0.2×
Current ratio1.3×-2.1×

Where this comes from

Calculated from Sana Biotechnology’s reported figures.

Based on the most recent quarter.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sana Biotechnology's book value per share?
Sana Biotechnology (SANA) reported book value per share of $0.43 in Q1 2026.
How has Sana Biotechnology's book value per share changed year-over-year?
Sana Biotechnology's book value per share decreased by 51.1% year-over-year, from $0.88 to $0.43.
What is the long-term trend for Sana Biotechnology's book value per share?
Over 5 years (2020 to 2025), Sana Biotechnology's book value per share has grown at a -54.4% compound annual growth rate (CAGR), from -$32.36 to $0.64.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.